Global microRNA Reverse Transcription Market, By Product Type (Instruments, Kits and Reagents, Consumables), Services ( Sample Collection, Other Services), Method (Reverse Transcription & qPCR), Application (Cancer, Kidney Disease, Neurological Disease, Cardiovascular Disease, Others), End User (Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Diagnostic Centers) Industry Trends and Forecast to 2029.
Global microRNA Reverse Transcription Market Analysis and Insights
MicroRNA are small endogenous RNA that regulates gene expression post-transcriptionally. MicroRNA are abundantly found in the mammalian types and target approximately 60% of the genes of humans and other mammals. MicroRNA reverse transcription is a crucial regulator of gene expression and a promising candidate for biomarker development.
A single microRNA can target hundreds of mRNAs and influence the expression of many genes. Further, microRNA reverse transcription involved in many allergies’ diseases including eosinophilic esophagitis, asthma and many others which is expected to increase the demand for microRNA reverse transcription. Current methodologies used for microRNA reverse transcription such as RNA-sequencing, microarrays and quantitative PCR are expected to boost the market growth.
Increasing prevalence of cancer, neurological disorder and others are expected to drive the microRNA reverse transcription market. In addition, the microRNA reverse transcription market is expected to rise exponentially due to further development in genomics technologies and computational approaches. Further, therapeutics demonstration in preclinical studies using these molecules is anticipated to increase the R&D investment in the coming years.
Also, there are various kits available such as the TaqMan, microRNA reverse transcriptase is specifically designed to generate specific cDNA, for the use with the TaqMan microRNA assays is also expected to increase the growth of microRNA reverse transcriptase market. This increase in the demand for microRNA reverse transcription has encouraged the key market players to implement newer technologies and strategies to improve the devices in the respective categories through product launches, acquisition, strategies and agreements.
The global microRNA reverse transcription market is supportive and aims to reduce the progression of the cancer, neurological disease. Data bridge market research analyses that global microRNA reverse transcription market will grow at a CAGR of 16.4% during the forecast period of 2022 to 2029.
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2019 - 2014) |
|
Quantitative Units |
Revenue in USD Million, Pricing in USD |
|
Segments Covered |
By Product Type (Instruments, Kits and Reagents, Consumables), By Services ( Sample Collection, Other Services), By Reverse Transcription & qPCR), Application (Cancer, Kidney Disease, Neurological Disease, Cardiovascular Disease, Others), By End User (Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Diagnostic Centers) |
|
Market Players Covered |
Thermofisher Scientific Inc., Agilent, Illumina, Inc., Merck KgaA, QIAGEN, Bio-Rad Laboratories, Inc., MiRXES Pte Ltd., Abcam plc, Takara Bio Inc., Quantabio, Horizon Discovery Ltd., NanoString., BioGenex, SeqMatic LLC, GenoSensor, LLC, OriGene Technologies, Inc., System Biosciences, LLC. , HTG Molecular Diagnostics, Inc., GeneCopoeia, Inc., New England Biolabs, Miltenyi Biotec and/or its affiliates, Applied Biological Materials Inc. (abm), Norgen Biotek Corp., Nanjing Vazyme Biotech Co.,Ltd. |
Global microRNA Reverse Transcription Market
Drivers
- Increasing Prevalence of Cancer and Neurological Disorder
MicroRNA reverse transcription is used for biomarkers in cancer through mediated intercellular communication in neurology for the diagnosis and prognosis of alzheimer’s disease. MicroRNA reverse transcription could also be used in other fields like cardiology, as a faster and more accurate means of diagnosis for acute cardiovascular disease or heart failure and in the case of infectious diseases for the diagnosis of sepsis. Consequently, expression profiling of microRNA in human cancers correlates with cancer detection, staging, progression, and response to therapies, which boosts the microRNA reverse transcription market.
- Increasing Increase in the Early Diagnosis Rate
With the increase in the successful diagnosis of chronic disease including cancer, anemia, type two diabetes, and others, improved health care professionals and regular training sessions for the professionals for conducting tests accounted for the improvement of diagnosis rate across the globe. Healthcare IT also has the potential, and they are putting in efforts that enhance the rate of diagnosis seeking, and they can also reduce the diagnostics errors. It also helps in detecting the risks associated with the diagnostic process and helps determine the range of the problem. Healthcare IT vendors also share and conduct to share the user experiences. This will help evaluate the consequences of the diagnostic errors, which is helping in improving the rate of diagnosis across various regions of the world. several associations and organizations are taking initiatives to spread awareness about new advanced microRNA sequencing products and technology.
Opportunities
- Rise in Government Funding for Healthcare
Including government, federations, and major market players create opportunities across developing countries. These initiatives by the players and government are helping the users reach out for taking advantage of the policies made for low-income and developing nations and making them aware of the diseases that are preventable if diagnosed earlier.
Restraints/Challenges
However, modern technology microRNA reverse transcription devices lead to the high cost of treatment. The kits require a huge cost for the development process. As the materials need to be sourced and require raw material, they should meet different regulations and others that add up the products' cost. Additionally, the process is time-consuming as it needs sufficient time to fully mature before bringing in the market for use.
Furthermore, any changes that must be re-verified will impact time. The growing developments demanded an effective investment for successful operations and a project risk management plan. The establishment of R&D for conducting research entails high cost, which leads to expensive point of care devices. Thus, this factor is acting as a major restrain for the market.
Global microRNA reverse transcription market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on microRNA reverse transcription market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
MicroRNA are small endogenous RNA that regulates gene expression post-transcriptionally. MicroRNA are abundantly found in the mammalian types and target approximately 60% of the genes of humans and other mammals. MicroRNA reverse transcription is a crucial regulator of gene expression and a promising candidate for biomarker development.
A single microRNA can target hundreds of mRNAs and influence the expression of many genes. Further, microRNA reverse transcription involved in many allergies’ diseases including eosinophilic esophagitis, asthma and many others which is expected to increase the demand for microRNA reverse transcription. Current methodologies used for microRNA reverse transcription such as RNA-sequencing, microarrays and quantitative PCR are expected to boost the market growth.
Global microRNA reverse transcription market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Post COVID-19 Impact on Global microRNA Reverse Transcription Market
The COVID-19 has negatively affected the healthcare market and also, covid-19 pandemic is expected to leave a long lasting impact in the global microRNA reverse transcription market. The outbreak of the virus forced the general citizens to deal with the virus and its management. This virus has greatly affected the economic sector. The healthcare industry is set to experience a few structural changes in 2022 due to the increasing prevalence of infectious diseases.
Increase in geriatric population and diseases have driven the overall growth of global microRNA reverse transcription market. However, increase in cost in diagnostic devices is expected to hinder the market growth.
Recent Development
- In September 2021, Bio-Rad Laboratories, Inc. announced the partnership with Seegene, Inc., a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products. This have increased company’s product portfolio.
- In 2020, Thermo Fisher Scientific Inc., throughout the pandemic, they’ve worked closely with the highest levels of governments and healthcare institutions around the world, as well as with the pharmaceutical and biotech industry to support efforts in research, diagnostic testing, development and production.
Global microRNA Reverse Transcription Market
The global microRNA reverse transcription market based on product type, services, method, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Product Type
- Instruments
- Kits and Reagents
- Consumables
On the basis of product type, the global microRNA reverse transcription market is segmented into Instruments, kits and reagents, consumable.
Services
- Sample Collection
- Other Services
On basis of by services, the global microRNA reverse transcription market is segmented into sample collection, other services.
Method
- Reverse Trnscription
- qPCR
On the basis of method, the global microRNA reverse transcription market is segmented into by Reverse Transcription & qPCR.
Application
- Cancer
- Kidney Disease
- Neurological Disease
- Cardiovascular Disease
- Others
On the basis of by application , the global microRNA reverse transcription market is segmented into cancer, kidney disease, neurological disease, cardiovascular disease, others.
End User
- Academic And Research Institutes
- Biopharmaceutical Companies
- Contract Research Organizations
- Diagnostic Centers
On the basis of by end user , the global microRNA reverse transcription market is segmented into academic and research institutes, biopharmaceutical companies, contract research organizations, diagnostic centers.
Competitive Landscape and Global MicroRNA Reverse Transcription Market Share Analysis
The global microRNA reverse transcription market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on global microRNA reverse transcription market.
Some of the key players operating in the global microRNA reverse transcription market are Thermofisher Scientific Inc., Agilent, Illumina, Inc., Merck KgaA, QIAGEN, Bio-Rad Laboratories, Inc., MiRXES Pte Ltd., Abcam plc, Takara Bio Inc., Quantabio, Horizon Discovery Ltd., NanoString., BioGenex, SeqMatic LLC, GenoSensor, LLC, OriGene Technologies, Inc., System Biosciences, LLC. , HTG Molecular Diagnostics, Inc., GeneCopoeia, Inc., New England Biolabs, Miltenyi Biotec and/or its affiliates, Applied Biological Materials Inc. (abm), Norgen Biotek Corp., Nanjing Vazyme Biotech Co.,Ltd.
SKU-
